Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors
JP Desager, Y Horsmans - Clinical pharmacokinetics, 1996 - Springer
Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase is the key enzyme of
cholesterol synthesis. HMG-CoA reductase inhibitors are potent reversible inhibitors of this …
cholesterol synthesis. HMG-CoA reductase inhibitors are potent reversible inhibitors of this …
Sterol absorption by the small intestine
SD Turley, JM Dietschy - Current opinion in lipidology, 2003 - journals.lww.com
Intestinal cholesterol absorption represents a major route for the entry of cholesterol into the
body's miscible pools and therefore can potentially impact the plasma LDL-cholesterol …
body's miscible pools and therefore can potentially impact the plasma LDL-cholesterol …
EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones
European Association for the Study Of the Liver - Journal of hepatology, 2016 - Elsevier
Gallstones or cholelithiasis are a major public health problem in Europe and other
developed countries and affect up to 20% of the population. Gallstone disease is the most …
developed countries and affect up to 20% of the population. Gallstone disease is the most …
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial
CM Ballantyne, J Houri, A Notarbartolo, L Melani… - Circulation, 2003 - Am Heart Assoc
Background—Despite the established efficacy of statins, many patients do not achieve
recommended LDL cholesterol (LDL-C) goals. Contributing factors may be inadequate …
recommended LDL cholesterol (LDL-C) goals. Contributing factors may be inadequate …
[图书][B] Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II).
National Cholesterol Education Program (US). Expert … - 1993 - books.google.com
Dr. DeWitt Goodman had agreed to be a member of this second Adult Treatment Panel at
the time of his dismayingly early death in November 1991. Dr. Goodman served with …
the time of his dismayingly early death in November 1991. Dr. Goodman served with …
Effects of legume consumption on serum cholesterol, biliary lipids, and sterol metabolism in humans
WC Duane - Journal of lipid research, 1997 - ASBMB
Legume consumption appears to lower serum cholesterol and to increase cholesterol
saturation of bile, but the mechanisms of these effects have not been established. We …
saturation of bile, but the mechanisms of these effects have not been established. We …
Statin use and the risk of cholecystectomy in women
CJ Tsai, MF Leitzmann, WC Willett, EL Giovannucci - Gastroenterology, 2009 - Elsevier
BACKGROUND & AIMS: Statins can reduce biliary cholesterol secretion independently of
their ability to inhibit cholesterol synthesis. Statins also prevent the formation of gallstones in …
their ability to inhibit cholesterol synthesis. Statins also prevent the formation of gallstones in …
Combination therapy of rosuvastatin and ezetimibe in patients with high cardiovascular risk
YJ Yang, SH Lee, BS Kim, YK Cho, HJ Cho… - Clinical …, 2017 - Elsevier
Purpose The aim of this study was to evaluate the efficacy and tolerability of
rosuvastatin/ezetimibe combination therapy in Korean patients with high cardiovascular risk …
rosuvastatin/ezetimibe combination therapy in Korean patients with high cardiovascular risk …
Current views on genetics and epigenetics of cholesterol gallstone disease
Cholesterol gallstone disease, one of the commonest digestive diseases in western
countries, is induced by an imbalance in cholesterol metabolism, which involves intestinal …
countries, is induced by an imbalance in cholesterol metabolism, which involves intestinal …
α-Asarone inhibits HMG-CoA reductase, lowers serum LDL-cholesterol levels and reduces biliary CSI in hypercholesterolemic rats
L Rodríguez-Páez, M Juárez-Sanchez, J Antúnez-Solís… - Phytomedicine, 2003 - Elsevier
Our results showed that α-asarone was an inhibitor of hepatic HMG-CoA reductase and that
the administration of α-asarone at 80 mg/kg body wt. for 8 days decreased serum cholesterol …
the administration of α-asarone at 80 mg/kg body wt. for 8 days decreased serum cholesterol …